does eli lilly make semaglutide Earnings from Lilly, Novo Nordisk, and Hims & Hers Health Ozempic Maker Novo Nordisk Asks

Medicare Part D Gross Spending on GLP-1s Increased Five-Fold Between 2019 and 2024, But Estimated Rebates of Around 50% Mean That Net Spending is Much Lower Gross Medicare Part D spending on GLP-1s in 2024 (not accounting for rebates) totaled $27.5 billion, a five-fold increase from 2019, reflecting an expansion in use of GLP-1s with more recent FDA approvals for type 2 diabetes

Dietitian guidance for GLP-1 users frequently lists electrolytes among the foundational supports for exactly this reason

This represents an average additional fat loss of about 1.8 kg (4 pounds) over 12 weeks attributable to the peptide

Healthy individuals secrete approximately 10-15 picomoles per liter of GLP-1 after meals, with wide individual variation based on genetics and lifestyle